Navigation Links
Eqalix Enters Sponsored Research Agreement with Temple University
Date:12/11/2012

Reston, VA (PRWEB) December 11, 2012

Under the agreement, Eqalix and Temple Bioengineering Chair and Professor Peter I. Lelkes will jointly advance the development of its three breakthrough technologies for regenerative medicine – protein-based skin substitute, regenerative blood vessels and nerve endings and regeneration of damaged and traumatized organs.

“This arrangement with Temple University works well with our strategy as an emerging company to maintain low overhead costs while accessing leading scientific expertise for the development of our product candidates,” said Eqalix Chairman and CEO Joseph P. Connell. “At the same time, we are building another example of a collaborative effort between the private sector and academia to further the development of novel approaches to treat diseases requiring improved therapies that will address the unmet needs of patients.”

Eqalix is an emerging regenerative medicine development company with a goal of enhancing the quality of life of consumers and patients by providing novel nano-materials for the repair and regeneration of diseased, traumatized and aging tissues. Its innovative technologies are intended to revolutionize the unmet needs in multiple commercial and therapeutic applications in the Regenerative Medicine space.

“We are excited and enthusiastic about entering into a Sponsored Research Agreement with a visionary start-up company such as Eqalix that will entail groundbreaking research in regenerative engineering, as well as the development of innovative and affordable products for wound care and cosmetic applications alike,” said Lelkes, who also serves as director of the Institute for Regenerative Medicine and Engineering in Temple’s School of Medicine.

Eqalix has received exclusive commercial licensing from other Philadelphia institutions for several groundbreaking technologies being developed in the fields of aesthetic dermatology, the consumer market for beauty and skin care, acute and chronic wounds requiring skin replacement, vascular replacements and the repair of traumatic damage to peripheral nerves.

Eqalix plans to leverage these technologies to develop and commercialize: a) plant protein-based nano-fiber scaffolds for use in aesthetic dermatology and wound healing markets; b) small-diameter hybrid vessels that reduce graft thrombogenicity and promote the creation of a functional endothelium after implantation; and c) three-dimensional tissue scaffolds with tunable properties for tissue and organ replacement and repair.

The technologies move the bar higher and intend to replicate the function of damaged, diseased or aging tissues by providing “implants” or scaffolds that are non-immunogenic, bio-compatible, and intended to restore the features and function of the damaged tissue by using the body’s own repair mechanisms. Eqalix is attempting to create skin without scarring and contraction, blood vessels without clotting, repair of injured nerves and organ beyond current capabilities.

“These lofty goals, although seemingly futuristic, are in the immediate realm of scientific possibilities today --- and at Eqalix,” said Connell.

Temple’s new bioengineering department was established in January 2012. Housed in the College of Engineering, Temple’s fastest growing college, the department seeks to provide a well-rounded, in-depth education and a world-class research experience at the interface of engineering, the life sciences and medicine, with the goal of promoting scientific discovery, as well as the development of new technologies that will benefit humanity.

Eqalix, Inc. is a privately held Virginia based C-Corporation located in Reston, VA.
Contact: Joseph P. Connell, 910-233-0806; jconnell (at) eqalix (dot) com

Read the full story at http://www.prweb.com/releases/2012/12/prweb10213704.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
2. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
3. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
4. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
5. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
6. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
7. Centers for Medicare & Medicaid Services Win 2012 National Cybersecurity Innovation Award
8. Nu Skin Enterprises Enters Into Agreement To Acquire NOX Technologies
9. Cell Therapeutics Reports on Cooperative Group Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
10. Wolters Kluwer Research Now Available via Bloomberg Tradebook
11. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... Kara Dwyer Dodge grew up hearing stories of the sea monster her father ... found a sea turtle entangled in the lines of one of his lobster pots. He ... because no one could remember ever seeing one so large so close to shore. After ...
(Date:12/6/2016)... Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today reported its ... ended September 30, 2016. ... , SQI is a ... develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. ... $1.4 million more than tripling prior years revenue. ...
(Date:12/6/2016)... ... December 06, 2016 , ... The ... asking the Federal Drug Administration (FDA) to consider OA as a serious disease. ... concerned about the growing population of OA patients, many of whom may experience ...
(Date:12/6/2016)... and Albany, NY (PRWEB) , ... December 06, ... ... control system integrator of custom industrial automation and IT solutions, today announced the ... Superior Controls has reliably delivered professionally executed automation and control systems integration services ...
Breaking Biology Technology:
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
(Date:11/16/2016)... Calif. , Nov. 16, 2016 ... user experience and security for consumer electronics, and ... the financial and retail industry, today announced a ... and convenient way to authenticate users of mobile ... Sensory,s TrulySecure™ software which requires no ...
(Date:11/14/2016)... 14, 2016  Based on its recent ... & Sullivan recognizes FST Biometrics with the ... Visionary Innovation Leadership. FST Biometrics emerged as ... market by pioneering In Motion Identification (IMID) ... seamless, and non-invasive verification. This patented solution ...
Breaking Biology News(10 mins):